title: Depot neuroleptics : a Scandinavian view.
abstract: Between 1974 and 1978, the prescription of long-acting neuroleptics (LAN) in Sweden has doubled in terms of treatment units per 1,000.000 inhabitants and of percent of total neuroleptic sales (from 6 to 13%). The trend is similar in Denmark, but less pronounced in Norway. Psychotic patients represent the almost exclusive indication. In the author's department, the percentage of LANs administered to psychotics is as high as 47.5%. The efficacy of the pharmacological treatment in terms of short hospital stay and rapid control of relapses is increased by intensive rehabilitation programmes.
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D006801:Humans; D007902:Length of Stay; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000534:rehabilitation; D012537:Scandinavian and Nordic Countries; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations